NCT02388750View on ClinicalTrials.gov

Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV)

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 7, 2017

Study Completion Date

August 7, 2017

Conditions
NauseaVomiting
Interventions
DRUG

Palonosetron

Palonosetron 0.5 mg every other day until completion of radiation and at least one hour prior on days of RT

RADIATION

Low or moderate risk radiotherapy

Low or moderately emetogenic radiotherapy will be given to all patients on study.

Trial Locations (1)

M4N3M5

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Dr. Edward Chow

OTHER

NCT02388750 - Prospective Study of Palonosetron in Radiation Induced Nausea and Vomiting (RINV) | Biotech Hunter | Biotech Hunter